Mrv1909 01292016492D 17 18 0 0 0 0 999 V2000 1.7096 0.3359 0.0000 Zn 0 0 0 0 0 0 0 0 0 0 0 0 1.9690 -0.4593 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.3014 -1.7691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.3488 1.0419 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.8846 0.3359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.4588 -0.9440 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.8670 0.3189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.1264 1.0419 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.6379 -0.4593 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.3014 -0.9440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4763 1.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0807 -0.8633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7953 -0.4593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.8846 1.7691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0419 0.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1264 -0.4593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7096 1.7691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 5 1 0 0 0 0 2 10 1 0 0 0 0 3 10 2 0 0 0 0 4 11 2 0 0 0 0 5 9 1 0 0 0 0 5 11 1 0 0 0 0 6 13 1 0 0 0 0 6 16 1 0 0 0 0 7 15 1 0 0 0 0 7 16 2 0 0 0 0 8 17 1 0 0 0 0 9 10 1 0 0 0 0 9 12 1 6 0 0 0 11 14 1 0 0 0 0 12 13 1 0 0 0 0 13 15 2 0 0 0 0 14 17 1 0 0 0 0 M END > DB09221 > drugbank > NCCC(=O)N1[Zn]OC(=O)[C@@H]1CC1=CN=CN1 > InChI=1S/C9H14N4O3.Zn/c10-2-1-8(14)13-7(9(15)16)3-6-4-11-5-12-6;/h4-5,7H,1-3,10H2,(H3,11,12,13,14,15,16);/q;+2/p-2/t7-;/m0./s1 > IGXZLYMCFZHNKW-FJXQXJEOSA-L > C9H12N4O3Zn > 289.6 > 288.020082 > 4 > 29 > 1.3478554655569137 > 23.293044733660174 > 1 > 2 > 0 > 0 > (4S)-3-(3-aminopropanoyl)-4-[(1H-imidazol-5-yl)methyl]-1-oxa-3-aza-2-zincacyclopentan-5-one > -1.16 > -2.7851999999999997 > -0.85 > 0 > 2 > 2 > 1 > 17.609832311855943 > 12.92082591871804 > 9.127275111191093 > 101.31 > 53.8343 > 4 > 1 > 4.11e+01 g/l > fidaxomicin > 0 > DB09221 > experimental > Polaprezinc > beta-Alanyl-L-histidinato zinc; Polaprezinc; Zinc L-carnosine > Remedient > Promac; Promac-D $$$$